AI assistant
Sending…
CVS HEALTH Corp — Director's Dealing 2012
Oct 3, 2012
29875_dirs_2012-10-03_e4687042-726e-47b4-a6d8-584a40504ace.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CVS CAREMARK CORP (CVS)
CIK: 0000064803
Period of Report: 2012-10-01
Reporting Person: Moriarty Thomas M (EVP & General Counsel)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-10-01 | Common Stock | P | 6164 | $48.67 | Acquired | 6164 | Direct |
| 2012-10-01 | Common Stock (pep) | A | 6164 | $48.67 | Acquired | 6164 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-10-01 | Stock Option | $48.67 | A | 61640 | Acquired | 2022-10-01 | Common Stock (61640) | Direct |
Footnotes
F1: Consists of matching Restricted Stock Units awarded pursuant to Issuer's Partnership Equity Program under the 2010 Incentive Compensation Plan. Restrictions lapse 10/1/2017.
F2: Option becomes exercisable in three equal annual installments, commencing 10/1/2015.
More from CVS HEALTH Corp
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 18
Regulatory Filings
2026
May 7
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 6
Major Shareholding Notification
2026
Apr 30
Annual Report
2026
Apr 3
Proxy Solicitation & Information Statement
2026
Apr 3
Proxy Solicitation & Information Statement
2026
Apr 3